HAC (Russian)
RSCI (Russian)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services


DOI: https://doi.org/10.29296/25877305-2018-04-13
Download full text PDF

L. Idrisova, Candidate of Medical Sciences; Professor A. Solopova, MD; Professor A. Makatsaria, MD; V. Moskvicheva; A. Surenkov I.M. Sechenov First Moscow State Medical University (Sechenov University)

The paper describes current medical rehabilitation techniques that can restore sexual function in women who have undergone a treatment cycle for breast cancer.

breast cancer
sexual function
medical rehabilitation

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

  1. Feeney L., Tormey S., Harmon D. Breast cancer and chronic pain: a mixed methods review // Ir. J. Med. Sci. – 2018. DOI: 10.1007/s11845-018-1760-y.
  2. Brummett C. Chronic pain following breast surgery // Tech. Reg. Anesth. Pain Manag. – 2011; 15 (3): 124–32.
  3. Duijts S., Stolk-Vos A., Oldenburg H. et al. Characteristics of breast cancer patients who experience menopausal transition due to treatment // Climacteric. – 2011; 14 (3): 362–8.
  4. Salonen P., Tarkka M., Kellokumpu-Lehtinen P. et al. Effect of social support on changes in quality of life in early breast cancer patients: a longitudinal study // Scand. J. Caring Sci. – 2013; 27 (2): 396–405.
  5. Nathorst-Boos J., Floter A., Jarkander-Rolff M. et al. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido–effects on sexuality and psychological general well-being // Maturitas. – 2006; 53 (1): 11–8.
  6. Nunez G., Pinczowski H., Zanellato R. et al. Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-blind, randomized, crossover, pilot phase II trial // J. Pain Symptom Manag. – 2013; 45 (6): 969–79.
  7. Buijs C., Mom C., Willemse P. et al. Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study // Breast Cancer Res. Treat. – 2009; 115 (3): 573–80.
  8. Anisimov V.N. Svetovoj rezhim, risk vozniknovenija raka. Protivoopuholevoe dejstvie melatonina // Rus. med. zhurn. – 2007; 25: 1915–8.
  9. Kvetnaja T., Bocharova K. Melatonin i patologija pozhilogo vozrasta // Vrach. – 2014; 6: 53–6.
  10. Anisimov V.N. Melatonin: rol' v organizme, primenenie v klinike / SPb: Sistema, 2007; 40 s.
  11. Tananakina E.N. Povyshenie effektivnosti lechenija matochnyh krovotechenij u zhenschin reproduktivnogo vozrasta v sochetanii s ekstragenital'noj patologiej. Dis. … kand. med. nauk. Lugansk, 2017.
  12. Ljubota R.V. Primenenie metformina v lechenii raka molochnoj zhelezy u bol'nyh s metabolicheskim sindromom // Opuholi zhenskoj reproduktivnoj sistemy. – 2015; 11 (4): 18–24.
  13. Loprinzi C., Abu-Ghazaleh S., Sloan J. et al. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer // J. Clin. Oncol. – 1997; 15 (3): 969–73.
  14. Pfeiler G., Glatz C., Konigsberg R. et al. Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients // Climacteric. – 2011; 14 (3): 339–44.
  15. Donders G., Neven P., Moegele M. et al. Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets Gynoflor® for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study // Breast Cancer Res. Treat. – 2014; 145 (2): 371–9.
  16. Wills S., Ravipati A., Venuturumilli P. et al. Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator // J. Oncol. Pract. – 2012; 8 (3): 144–8.
  17. Lee Y., Chung H., Kim J. et al. Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial // Obstet. Gynecol. – 2011; 117 (4): 922–7.
  18. Dahir M., Travers-Gustafson D. Breast cancer, aromatase inhibitor therapy, and sexual functioning: a pilot study of the effects of vaginal testosterone therapy // Sexual Med. – 2014; 2 (1): 8–15.
  19. Witherby S., Johnson J., Demers L. et al. Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study // The Oncologist. – 2011; 16 (4): 424–31.
  20. Oliveira M., Gurgel M., Amorim B. et al. Long term effects of manual lymphatic drainage and active exercises on physical morbidities, lymphoscintigraphy parameters and lymphedema formation in patients operated due to breast cancer: A clinical trial // PLoS One. – 2018; 13 (1): e0189176.
  21. Speck R., Gross C., Hormes J. et al. Changes in the Body Image and Relationship Scale following a one-year strength training trial for breast cancer survivors with or at risk for lymphedema // Breast Cancer Res. Treat. – 2010; 121 (2): 421–30.
  22. Talaeva Sh.Zh., Chichua N.A., Manasheva A.S. i dr. Opyt primenenija rekonstruktivno-plasticheskih operatsij pri rake molochnoj zhelezy // Onkologija i radiologija Kazahstana. – 2016; 41 (3): 186–92.